Suzanne C. Cannegieter
Suzanne C. Cannegieter publishes mostly in Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Venous Thromboembolism Diagnosis and Management, Blood Coagulation and Thrombosis Mechanisms and Atrial Fibrillation Management and Outcomes.
- World rank
- #124,111 of 7,710,434 ranked researchers
- Rank in Netherlands
- #3,014 of 107,149
- Works
- 513
- Citations
- 22k
- Citations per work
- 43.4
What does Suzanne C. Cannegieter research?
Suzanne C. Cannegieter's work is mostly in Medicine (65%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences33264.7%
- Medicine33264.7%
- Everything else18135.3%
- 1Internal Medicine22% of their works
- 2Cardiology and Cardiovascular Medicine16% of their works
- 3Surgery10% of their works
- 4Hematology10% of their works
- 5Endocrinology, Diabetes and Metabolism4% of their works
- 6Neurology3% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Blood Coagulation and Thrombosis Mechanisms
- Atrial Fibrillation Management and Outcomes
- Diagnosis and Treatment of Venous Diseases
- COVID-19 Clinical Research Studies
- Cerebral Venous Sinus Thrombosis
- Blood properties and coagulation
- Acute Myocardial Infarction Research
Which keywords describe Suzanne C. Cannegieter's research?
The keywords of their largest research topics: Antithrombotic Therapy, Clinical Practice Guidelines, Pulmonary Embolism, Venous Thromboembolism, Hemostasis, Guidelines, Protease-Activated Receptors and Thrombin.
- Acute Coronary Syndromes
- Fibrinogen
- Cerebral Venous Thrombosis
- Clinical Characteristics
- Chronic Venous Insufficiency
- Atrial Fibrillation
- Thrombin
- Guidelines
- Venous Thromboembolism
- Clinical Practice Guidelines
- Antithrombotic Therapy
- Pulmonary Embolism
- Hemostasis
- Protease-Activated Receptors
- Anticoagulant Therapy
- Epidemiology
- Varicose Veins
- SARS-CoV-2
- Idiopathic Intracranial Hypertension
- Transglutaminases
- Myocardial Infarction
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Antithrombotic Therapy4282 topics
- Clinical Practice Guidelines3562 topics
- Pulmonary Embolism3071 topic
- Venous Thromboembolism3071 topic
- Hemostasis1422 topics
- Guidelines1222 topics
- Protease-Activated Receptors1211 topic
- Thrombin1211 topic
- Anticoagulant Therapy1031 topic
- Atrial Fibrillation1031 topic
- Epidemiology792 topics
- Chronic Venous Insufficiency491 topic
- Varicose Veins491 topic
- Clinical Characteristics301 topic
- SARS-CoV-2301 topic
- Cerebral Venous Thrombosis261 topic
- Idiopathic Intracranial Hypertension261 topic
- Fibrinogen211 topic
- Transglutaminases211 topic
- Acute Coronary Syndromes191 topic
- Myocardial Infarction191 topic
Where does Suzanne C. Cannegieter work?
Suzanne C. Cannegieter's main affiliation in the publication record is Leiden University Medical Center, Netherlands.
How many publications and citations does Suzanne C. Cannegieter have?
OpenAlex counts 513 works and 22,283 citations for Suzanne C. Cannegieter, an h-index of 68, ranking #124,111 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Suzanne C. Cannegieter. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.